Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0023 | 0.9 |
mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |